Lupin informed that it has received an approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Minzoya (Levonorgestrel and Ethinyl Estradiol tablets, and Ferrous Bisglycinate tablets).
| Subscribe To Our Free Newsletter |
